R & D
Molecular Nuclear Imaging
Bring new hopes to patients through the most innovative nuclear diagnosis and treatment products.
The kick-off meeting of phase III clinical trial of rhTSH Drug SNA001 developed by SmartNuclide was held in Suzhou
SmartNuclide Biopharma Announces First Patient Treated in Phase 1/2 Clinical Trial of SNA001 for Well-Differentiated Thyroid Cancer
SmartNuclide’s SNA001 Receives NMPA’s First Investigational New Drug Approval for Recombinant Human TSH
Innovative Radiopharmaceutical Company SmartNuclide Closes Series Pre-A Financing
COPYRIGHT © 2020 SMARTNUCLIDE